2004
DOI: 10.1590/s0004-27302004000400021
|View full text |Cite
|
Sign up to set email alerts
|

Estadiamento do carcinoma diferenciado de tireóide pela classificação AJCC/TNM

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 2 publications
0
5
0
Order By: Relevance
“…There is growing evidence that a cut-off age of 45 years has led to overstaging in many DTC patients, and the use of a cut-off age of 55 years in the 8 th edition of the TNM ® staging system may prevent staging in low-risk patients. This new classification may also provide a more realistic assessment of disease mortality in high-risk patients 3 . A significant number of patients aged 45-55 years can be reclassified to stage I or II with application of the TNM ® 8 th edition 3 .…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…There is growing evidence that a cut-off age of 45 years has led to overstaging in many DTC patients, and the use of a cut-off age of 55 years in the 8 th edition of the TNM ® staging system may prevent staging in low-risk patients. This new classification may also provide a more realistic assessment of disease mortality in high-risk patients 3 . A significant number of patients aged 45-55 years can be reclassified to stage I or II with application of the TNM ® 8 th edition 3 .…”
Section: Discussionmentioning
confidence: 99%
“…This new classification may also provide a more realistic assessment of disease mortality in high-risk patients 3 . A significant number of patients aged 45-55 years can be reclassified to stage I or II with application of the TNM ® 8 th edition 3 . In this study, there was a statistical relationship between age >55 years and presence of malignant disease (p=0.0422), indicating that this change in age group may avoid less aggressive therapies in younger patients because of the better prognosis of thyroid cancer at earlier ages.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In recent years, the search for factors which can influence prognosis has been a constant, since they impact directly on the identification of patients who have a more aggressive disease, as well as its treatment and follow up 8 . Multiple series of cases have been assessed and numerous staging classifications have been proposed taking into account risk and prognostic factors (TNM, EORTC, UICC/AJCC, AGES, AMES, MACIS, Clinical classification, Ohio) 3, 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 . Nonetheless, the relative impact of each one of these indicators is yet to be clearly defined.…”
Section: Introductionmentioning
confidence: 99%